Key Record Dates
ClinicalTrials.gov Identifier: | NCT05415072 |
---|---|
Brief Title: | A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
First Submitted : | June 8, 2022 |
First Submitted that Met QC Criteria : | June 8, 2022 |
First Posted : | June 10, 2022 |
Last Update Submitted that Met QC Criteria : | March 21, 2023 |
Last Update Posted : | March 22, 2023 |